Print Page  |  Close Window

SEC Filings

8-K
PROTAGONIST THERAPEUTICS, INC filed this Form 8-K on 03/07/2017
Entire Document
 


Item 2.02. Results of Operations and Financial Condition.

On March 7, 2017, Protagonist Therapeutics, Inc. reported its financial results for the quarter and year ended December 31, 2016. A copy of the press release titled “Protagonist Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results,” is furnished pursuant to Item 2.02 as Exhibit 99.1 hereto and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit

  

Description

99.1    Press release, dated March 7, 2017, titled “Protagonist Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results.”

The information in this report, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Protagonist Therapeutics, Inc., whether made before or after the date hereof, regardless of any general incorporation language in such filing.